Lipella Pharmaceuticals Inc. (LIPO) stock
LIPOOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $2.27KP/E –Yield –
Lipella Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Lipella Pharmaceuticals's cash was $1.86M at Sep 30, 2025. For fiscal 2024 it was $2.18M, down 33.7% from the year before. The highest annual figure on record is $5.12M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $2.18M | -33.7% |
| FY2023 | Dec 31, 2023 | $3.29M | -35.7% |
| FY2022 | Dec 31, 2022 | $5.12M | +198.8% |
| FY2021 | Dec 31, 2021 | $1.71M | +182.6% |
| FY2020 | Dec 31, 2020 | $606.74K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2025 | Sep 30, 2025 | $1.86M | +37.1% |
| Q2 FY2025 | Jun 30, 2025 | $2.78M | +134.5% |
| Q1 FY2025 | Mar 31, 2025 | $4.23M | +100.7% |
| Q4 FY2024 | Dec 31, 2024 | $2.18M | -33.7% |
| Q3 FY2024 | Sep 30, 2024 | $1.35M | -43.8% |
| Q2 FY2024 | Jun 30, 2024 | $1.19M | -61.9% |
| Q1 FY2024 | Mar 31, 2024 | $2.11M | -47.6% |
| Q4 FY2023 | Dec 31, 2023 | $3.29M | -35.7% |
| Q3 FY2023 | Sep 30, 2023 | $2.41M | +1999.7% |
| Q2 FY2023 | Jun 30, 2023 | $3.11M | +615.8% |
| Q1 FY2023 | Mar 31, 2023 | $4.02M | +869.8% |
| Q4 FY2022 | Dec 31, 2022 | $5.12M | +198.8% |
| Q3 FY2022 | Sep 30, 2022 | $114.77K | -81.1% |
| Q2 FY2022 | Jun 30, 2022 | $434.98K | – |
| Q1 FY2022 | Mar 31, 2022 | $414.40K | – |
| Q4 FY2021 | Dec 31, 2021 | $1.71M | – |
| Q4 FY2020 | Dec 31, 2020 | $606.74K | – |
See a number that looks wrong?